GSK097 is a potent, BD2-selective BET inhibitor with >2000-fold selectivity for BRD4 BD2 over BD1 and solubility >1 mg/mL in FaSSIF. It is a valuable chemical probe for studying BD2-specific biology in oncology and inflammation research, enabling both in vitro mechanistic studies and in vivo model validation.
Molecular Weight:
339.395
CAS Number:
[2159137-02-5]
Formula:
C19H21N3O3
Target:
Epigenetic Reader Domain,Others
* VAT and and shipping costs not included. Errors and price changes excepted